Skip to Main Content

Author Details

Gord von Campe
Medical University of Graz
1992
32
16
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37907716Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.J Neurooncol2023
35326730MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.Cancers (Basel)2022
34195355Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump.Adv Mater Technol2021
33514740Synthetic skull bone defects for automatic patient-specific craniofacial implant design.Sci Data2021
33807050A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.Cancers (Basel)2021
34815988<i>MUG500+</i>: Database of 500 high-resolution healthy human skulls and 29 craniotomy skulls and implants.Data Brief2021
33939608AutoImplant 2020-First MICCAI Challenge on Automatic Cranial Implant Design.IEEE Trans Med Imaging2021
34340106Automatic skull defect restoration and cranial implant generation for cranioplasty.Med Image Anal2021
32812070Automatic identification of atypical clinical fMRI results.Neuroradiology2020
31935783Impact of Priming on Effectiveness of TMS in Detecting Language-eloquent Brain Areas in Tumor Patients.J Neurol Surg A Cent Eur Neurosurg2020
32765240Dissociating Arithmetic Operations in the Parietal Cortex Using 1 Hz Repetitive Transcranial Magnetic Stimulation: The Importance of Strategy Use.Front Hum Neurosci2020
32986199Correction to: Automatic identification of atypical clinical fMRI results.Neuroradiology2020
31386080Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network.Neurooncol Pract2019
30301187Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.Cancers (Basel)2018
29992433Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.J Neurooncol2018
30150718The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.Nat Med2018
27836394Pre- and postoperative neurocognitive deficits in brain tumor patients assessed by a computer based screening test.J Clin Neurosci2017
31386020Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?Neurooncol Pract2017
28128689Symmetry of the arcuate fasciculus and its impact on language performance of patients with brain tumors in the language-dominant hemisphere.J Neurosurg2017
28264062Interactive reconstructions of cranial 3D implants under MeVisLab as an alternative to commercial planning software.PLoS One2017
27251155Evaluation of a New Brain Tissue Probe for Intracranial Pressure, Temperature, and Cerebral Blood Flow Monitoring in Patients with Aneurysmal Subarachnoid Hemorrhage.Neurocrit Care2016
25462098Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.Clin Neurol Neurosurg2015
24253501Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.Br J Cancer2014
24321210Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.Int J Clin Pharmacol Ther2014
222973995-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies.Acta Neurochir (Wien)2012
22868403[Rapid frozen sections in neuropathology].Pathologe2012
20175026Multicentric tumor manifestations of high grade gliomas: independent proliferation or hallmark of extensive disease?Cent Eur Neurosurg2010
183631165-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion.Swiss Med Wkly2008
14638878Heralding manifestations of basilar artery occlusion with lethal or severe stroke.J Neurol Neurosurg Psychiatry2003
9751141Glutamate receptor subunits GluR1 and GluR2/3 distribution shows reorganization in the human epileptogenic hippocampus.Eur J Neurosci1998
9347345Morphology of dentate granule cells in the human epileptogenic hippocampus.Hippocampus1997
1604123[Bilateral deafness, an initial manifestation of meningeal carcinomatosis].Rev Neurol (Paris)1992
  • 1 - 32 of 32

Recommended Authors

Justin Z Wang
University of Toronto
Career Start Year 2013
Number of shared co-authors 0
Farshad Nassiri
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 0
Rohan Ramakrishna
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 0
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 0
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Nancy Ann Oberheim Bush
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
Gelareh Zadeh
University of Toronto
Career Start Year 2003
Number of shared co-authors 5
Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2002
Number of shared co-authors 1
Ichiyo Shibahara
Kitasato University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Paulina Due-T??nnessen
Oslo University Hospital
Career Start Year 2001
Number of shared co-authors 0
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 5
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 5
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Brian V Nahed
Harvard Medical School
Career Start Year 2000
Number of shared co-authors 0
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 4
Radim Jancalek
St. Anne University Hospital, Masaryk University
Career Start Year 1999
Number of shared co-authors 5
John A Boockvar
Lenox Hill Hospital
Career Start Year 1997
Number of shared co-authors 1
Sun Ha Paek
Seoul National University College of Medicine
Career Start Year 1996
Number of shared co-authors 0
Jorge A Gutierrez
Case Western Reverse University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Clark C Chen
University of Minnesota
Career Start Year 1994
Number of shared co-authors 0
Torstein R Meling
The National Hospital of Denmark, Rigshospitalet
Career Start Year 1993
Number of shared co-authors 3
Michael W McDermott
University of California san francisco
Career Start Year 1989
Number of shared co-authors 1
Marcos Tatagiba
University of Tubingen
Career Start Year 1989
Number of shared co-authors 1
Toshihiro Kumabe
Kitasato University School of Medicine
Career Start Year 1988
Number of shared co-authors 0
James T Rutka
Hospital for Sick Children
Career Start Year 1984
Number of shared co-authors 1
Wai Sang Poon
Prince of Wales Hospital
Career Start Year 1982
Number of shared co-authors 0
Mitchel S Berger
University of California san francisco
Career Start Year 1982
Number of shared co-authors 9
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Career Start Year 1979
Number of shared co-authors 0
Hubertus Maximilian Mehdorn
University Hospital Schleswig-Holstein
Career Start Year 1975
Number of shared co-authors 3
Maria Martinez-Lage
Massachusetts General Hospital
Career Start Year 1960
Number of shared co-authors 0

Collaborators

Christian F Freyschlag
Medical University of Innsbruck
Co-authored papers 6
Johanna Buchroithner
Johannes Kepler University
Co-authored papers 5
Stefan Oberndorfer
Karl Landsteiner University of Health Sciences
Co-authored papers 5
Christine Marosi
Medical University of Vienna
Co-authored papers 5
Georg Widhalm
Medical University of Vienna
Co-authored papers 5
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Co-authored papers 5
Josef Pichler
Kepler University Hospital
Co-authored papers 5
Serge Weis
Kepler University Hospital, Johannes Kepler University
Co-authored papers 4
Franz Payer
Medical University of Graz
Co-authored papers 4
G??nther Stockhammer
Medical University of Innsbruck
Co-authored papers 4
Johannes A Hainfellner
Medical University of Vienna
Co-authored papers 3
Kariem Mahdy Ali
Medical University of Graz
Co-authored papers 3
Stefanie Krassnig
Institute of Pathology, Medical University of Graz
Co-authored papers 3
Matthias Preusser
Medical University of Vienna
Co-authored papers 3
Claudius Thom??
Medical University Innsbruck
Co-authored papers 3
Dieter Schmalstieg
Co-authored papers 3
Martha Nowosielski
Medical University of Innsbruck
Co-authored papers 3
Thomas Czech
Co-authored papers 2
Johannes Kerschbaumer
Medical University of Innsbruck
Co-authored papers 2
Franz Marhold
Karl Landsteiner University of Health Sciences
Co-authored papers 2
Karin Dieckmann
Medical University of Vienna
Co-authored papers 2
Franz G W??rtz
Institute of Pathology, State Hospital Klagenfurt
Co-authored papers 2
Nick F Ramsey
Utrecht University
Co-authored papers 2
Adelheid Woehrer
Medical University of Vienna
Co-authored papers 2
Waltraud Kleindienst
Paracelsus Medical University Salzburg
Co-authored papers 1
Irene Slavc
Co-authored papers 1
Stefan Schweiger
Leibniz-Institut fuer Wissensmedien
Co-authored papers 1
Melitta Kitzwoegerer
Karl Landsteiner University of Health Sciences
Co-authored papers 1
Christine Haberler
Co-authored papers 1
Barbara Kiesel
Medical University of Vienna
Co-authored papers 1
Release 1.2